DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Brent Wisner - 3 Zantac - 3 Jennifer Moore - 2 Boehringer Ingelheim - 2 ” Moore - 2 “ - 1 Wisner - 1 ranitidine — - 1
Top related locs:
Delaware Florida Connecticut Oakland , California Britain U.S France's Sanofi Zantac
Top related orgs:
GSK - 3 Pfizer - 3 Sanofi - 2 Boehringer - 2 CNN - 1 Food and Drug Administration - 1 Delaware Supreme Court - 1 GlaxoSmithKline - 1

Search resuls for: "Brent Wisner"


3 mentions found


☆ GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion
  + stars: | 2024-10-09 | by ( ) edition.cnn.com   time to read: +3 min
CNN —GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday. GSK also said it would pay $70 million to settle a related whistleblower lawsuit filed by a Connecticut laboratory. Pfizer has agreed to settle most of the Zantac cases against it in state court, according to its most recent financial statement, and Sanofi in April announced that it was settling about 4,000 cases. Boehringer Ingelheim has not announced any major settlements, but is currently facing a trial over the drug in Oakland, California, state court. A majority of the remaining state court cases are in Delaware, where a judge in June allowed plaintiffs to present crucial expert testimony that Zantac caused cancer.
Persons: Jennifer Moore, Brent Wisner, Zantac, Boehringer Ingelheim, “, ” Moore, Wisner Organizations: CNN, GSK, Pfizer, Sanofi, Boehringer, Food and Drug Administration, Delaware Supreme Court Locations: Connecticut, Oakland , California, Delaware, Florida
☆ Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
  + stars: | 2024-06-03 | by ( Jenni Reid | ) www.cnbc.com   time to read: +1 min
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. LONDON — Shares of British pharmaceuticals giant GSK plunged 9% Monday, after a U.S. court ruled that scientific evidence could be presented in a stack of lawsuits relating to the discontinued heartburn drug Zantac. The Delaware State Court late on Friday ruled that plaintiffs' expert witnesses could testify in the roughly 75,000 cases alleging the once-popular drug ranitidine — sold under the brand name Zantac in the U.S. — may cause cancer. The companies involved deny there is a scientific consensus that the drug can be linked to any later development of cancers. In a statement Friday, GSK said it disagreed with the latest Delaware ruling and would immediately seek an appeal.
Persons: ranitidine —, Brent Wisner, Wisner Baum, Zantac Organizations: GlaxoSmithKline, Stevenage, GSK, Delaware State Court, France's, Pfizer, Germany's Locations: Britain, Delaware, U.S, France's Sanofi
☆ Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
  + stars: | 2024-04-05 | by ( ) edition.cnn.com   time to read: +3 min
Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi still faces about 20,000 lawsuits over Zantac in Delaware state court. That judge concluded that the opinions of the plaintiffs’ expert witnesses that Zantac can cause cancer were not supported by sound science. “We are pushing forward aggressively against GSK and Boehringer Ingelheim and are preparing for multiple trials in California state court this year,” Moore said. Lawsuits began piling up from people who said they developed cancer after taking Zantac.
Persons: Sanofi, “ Sanofi, Boehringer, Boehringer Ingelheim, Jennifer Moore, Brent Wisner, ” Moore, Zantac, ranitidine Organizations: Court, Sanofi, GSK, Pfizer, Boehringer, US Food and Drug Administration Locations: Delaware, Zantac, Wilmington, Florida, California
0 next >>
Total: 3